PHILADELPHIA, March  31, 2026  (GLOBE NEWSWIRE) -- Stockholder rights firm Kaskela Law announces that it is investigating Agilon Health, Inc. (NYSE:AGL) (&#34;Agilon&#34;) on behalf of the company&#39;s long-term investors.   Click

AGILON HEALTH STOCKHOLDER ALERT: Kaskela Law Firm Announces Stockholder Investigation of Agilon Health, Inc.and Encourages Long-Term AGL Stockholders to Contact the Firm

Agilon Health Faces Securities Fraud Investigation Amid Significant Stock Declines

<section class="insight" data-version="1">
 <section data-block="information">
 <h3>Information</h3>
 PHILADELPHIA, March 31, 2026 (GLOBE NEWSWIRE) -- Stockholder rights firm Kaskela Law announces that it is investigating Agilon Health, Inc. (NYSE:AGL) (&amp;#34;Agilon&amp;#34;) on behalf of the company&amp;#39;s long-term investors.  Click
 </section>

 <section data-block="ai-summary-paragraph">
 <h3>AI Summary</h3>
 Agilon Health is under investigation by Kaskela Law over alleged securities fraud involving misleading statements about medical costs, which contributed to an 85% stock price decline. This legal inquiry could further impact investor sentiment and stock performance in the near term.
 </section>

 <section data-block="ai-summary-bullets">
 <h3>Key Points</h3>
 <ul><li>Kaskela Law is investigating Agilon Health for securities fraud.</li><li>Claims involve false statements about medical costs affecting share prices.</li><li>Agilon&#039;s stock dropped 85% from over $44 to under $6.50.</li><li>Investors are encouraged to participate in potential legal action.</li><li>Investigations focus on misconduct by senior executives and board members.</li></ul>
 </section>

 <section data-block="companies-mentioned">
 <h3>Companies Mentioned</h3>
 <ul><li>Agilon Health, Inc. (AGL): AGL&#039;s stock is under pressure from ongoing investigations and potential legal actions.</li></ul>
 </section>

 <section data-block="category">
 <h3>Legal</h3>
 This situation falls under &#039;Legal&#039; as it involves a securities fraud investigation, potentially affecting Agilon Health&#039;s reputation and stock valuation, thereby aligning with legal concerns around corporate governance and investor rights.
 </section>

 <section data-block="market-moving">
 <h3>Market-Moving</h3>
 <ul><li>Investor participation in legal action may lead to further declines.</li><li>Potential for class action lawsuits could deter new investors.</li><li>Allegations of executive misconduct may lead to governance changes.</li></ul>
 </section>

 <section data-block="key-facts">
 <h3>Key Facts</h3>
 <ul><li>Agilon&#039;s stock fell from over $44.00 to less than $6.50.</li><li>Investigation focuses on period between April 15, 2021, and February 27, 2024.</li><li>Investors impacted by over $38.00 per share loss.</li></ul>
 </section>

 <section data-block="trading-thesis">
 <h3>Trading Thesis</h3>
 Given the investigation and potential legal ramifications, AGL faces bearish sentiment in the short term.
 </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link>PHILADELPHIA, March 31, 2026 (GLOBE NEWSWIRE) -- Stockholder rights firm <a href="https://www.globenewswire.com/Tracker?data=FAFuxoAWHAgQkiL0m7sRPKkN6BBEMnwV4-vkB_MAtp1quv5JhC636QTLe4GeZfmnkabCVjSkrOLCxeAdlZY06zNsv6GTzWKIGvzyzBK148s=" rel="nofollow" target="_blank">Kaskela Law</a> announces that it is investigating Agilon Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/AGL">AGL</a>) ("Agilon") on behalf of the company's long-term investors.  Click here for additional information: <a href="https://www.globenewswire.com/Tracker?data=gIa1UqwjfOSaduYcLwtPmCGKWWv48W1K2Q3CIDp2hFc4o_XX8ipATmJ1nWbfHadhbGD-wEsQeabvPPXyWiSEtOtrqx1T38LAUkwtQ2nA6C1EVvtzzECEAucNFiWRQrClADwxlyiQwa11NJbJv-cbKw==" rel="nofollow" target="_blank">https://kaskelalaw.com/case/agilon-health/</a>    Recently a securities fraud complaint was filed against Agilon on behalf of certain investors who purchased shares of the company's stock between April 15, 2021 and February 27, 2024.  According to the complaint, during that time period Agilon  and several of the company's senior executive officers made a series of materially false and misleading statements to investors about Agilon's medical costs.   As further detailed in the complaint, as the true information about the company's higher medical costs was disclosed as Agilon reported lower than expected financial results and expectations for future revenue, shares of the company's stock significantly declined in value, harming the company's long-term investors.  Specifically, Agilon's stock price declined approximately 85% in value during the relevant period from over $44.00 per share to less than $6.50 per share, a decline of over $38.00 per share.   "The allegations of misconduct involving the company's senior executives are deeply concerning. Our firm is investigating whether the members of Agilon's board of directors violated the securities laws or breached their fiduciary duties in connection with this alleged wrongdoing," said attorney D. Seamus Kaskela, who is leading the firm's investigation. Current Agilon shareholders who purchased or acquired their shares prior to May 1, 2023 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email at <a href="https://www.globenewswire.com/Tracker?data=Tq-Mf5fEH7MXqzEq2TYQCwt_iLy6_vWlIQjlFbzxoG6tcgKwuspAnsxSNftr1oUJMGh6nD0hgn6WXJjR-lYBjNBFFvri6lGFb6b667W2dtA=" rel="nofollow" target="_blank">skaskela@kaskelalaw.com</a> or <a href="https://www.globenewswire.com/Tracker?data=UfzGOWuE4PDS7LCxZVmBh3rdMOo1plwfRdlxYN6BV5CMSv-Wv8LA6mxEHDcg0Ra4UoHAARxUmrYjXrd5AHhwQ2YqUNtEd7wU5-m2c56Xcao=" rel="nofollow" target="_blank">abell@kaskelalaw.com</a>, to discuss their no-cost legal rights and options with respect to this matter. You can also click on the following link (or copy and paste it into your browser) to learn more about this investigation:    <a href="https://www.globenewswire.com/Tracker?data=gIa1UqwjfOSaduYcLwtPmCGKWWv48W1K2Q3CIDp2hFc4o_XX8ipATmJ1nWbfHadhbgtq8C_dDZ4IBZoCr50tfK6QvjCjWjLhhUajIi3-aBZsJK1LL5NBzbUcfEdJLqOOGpzMGrTrypFRMfO-cW8tWw==" rel="nofollow" target="_blank">https://kaskelalaw.com/case/agilon-health/</a>   ABOUT KASKELA LAW:    Kaskela Law exclusively represents investors in securities fraud, corporate governance, and merger &amp; acquisition litigation on a contingent basis. For additional information about the firm, including the firm's recent monetary recoveries for investors in mergers &amp; acquisition litigation, please visit our website (<a href="https://www.globenewswire.com/Tracker?data=MjpJ5fLJ05_iFVVHNtQWGzEuwtKuiZDszlw-_AN4R9NQCYEZsiW_EJAD5zAoBHiooTr6cdvS1TSDUwibWEGUYuzCrWoUKAeHh7BwNrqCaKE=" rel="nofollow" target="_blank">www.kaskelalaw.com</a>) or contact us today at (888) 715 – 1740.    KASKELA LAW LLC     D. Seamus Kaskela, Esquire    Adrienne Bell, Esquire    18 Campus Boulevard, Suite 100     Newtown Square, PA 19073     (484) 229 – 0750      <a href="https://www.globenewswire.com/Tracker?data=MjpJ5fLJ05_iFVVHNtQWG20WcKMXv-PJLXH3G-mcFjLz4fIf2tloGRftXFTm9b3V8vIIm00lTfsZYJLvhpy5zeGsT3yvP8RMtcPFKq3oTvQ=" rel="nofollow" target="_blank">www.kaskelalaw.com</a>    This communication may constitute attorney advertising in certain jurisdictions.    <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTY4MTE4NCM3NTExNDE0IzIwOTk5MzU="></img> <img alt="" src="https://ml.globenewswire.com/media/MDMyZDgyNmItYmEwYS00NTM2LWFiOTEtNzhhOWQ5MmM3MTFiLTExMTE1MDYtMjAyNi0wMy0zMS1lbg==/tiny/Kaskela-Law.png" referrerpolicy="no-referrer-when-downgrade"></img><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/46a37084-e0b3-48fa-b515-02e82ff9d30a"><img src="https://ml.globenewswire.com/media/46a37084-e0b3-48fa-b515-02e82ff9d30a/small/kaskela-law-logo1-jpg.jpg" border="0" width="150" height="149" alt="Primary Logo"></img></a>

Agilon Health is under investigation by Kaskela Law over alleged securities fraud involving misleading statements about medical costs, which contributed to an 85% stock price decline. This legal inquiry could further impact investor sentiment and stock performance in the near term.

agilon-health-stockholder-alert-kaskela-law-firm-announces-stockholder-investigation-of-agilon-health-inc-and-encourages-long-term-agl-stockholders-to-contact-the-firm

AGILON HEALTH STOCKHOLDER ALERT: Kaskela Law Firm Announces Stockholder Investigation of Agilon Health, Inc.and Encourages Long-Term AGL Stockholders to Contact the Firm

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News